Worldwide distributor of NSN parts and consumables located in the USA.
The last inventory check on this NSN was done on 06/04/2020. Due to rapid changes in inventory this may not be the current stock qty.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Lithium oxide and hydroxide
Inorganic bases n.E.S.; metal oxides, hydroxides and peroxides, n.E.S.
Chemicals-inorganic
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
ADPE- Represents items with no adp components
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
043940 - Chemicals noi
635 - Chemicals, other than drugs or sundries
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
C - Chemical corps items and all other chemicals not covered in other classificatons. note: when an item has a chemical proper shipp
W - Rating variable
W - Corrosive materials, un class 8 (corrosive label)
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
Historical data shows pricing from $1,010.84 to $1,684.73.. | |
Does NSN 6810-00-559-3261 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
Department Of The Navy, Brazil, Spain, Greece, and Turkey | |
What is the NIIN of NSN 6810-00-559-3261? | |
005593261 or 00-559-3261 | |
Does NSN 6810-00-559-3261 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6810-00-559-3261? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Mar 18, 1968 |
Ld50 lc50 mixture: no data provided by manufacturer
routes of entry: inhalation: yes skin: no ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: acute- this material is corrosive to
skin, eyes (may cause blindness), nose, throat, respiratory &
gastrointestinal tracts. The use of this product in industrial &
commercial applications presents no significant toxicity hazard.
chronic- unknown. Target organs: n/p.
explanation of carcinogenicity: product is not indicated to be
carcinogenic.
effects of overexposure: lithium carbonate is used therapeutically at
500-2000 mg/day oral doses for specific metal disorders.
therapeutic effects occur aat blood levels of 2.8-8.3 mg lithium
per liter. Minimal signs of toxic ity may also occur at these
therapeutic levels and involve primarily gastrointestinal upset.
increased dosages can produce tremors, drowsiness and insteady
gait. Signs of toxicity resolve rapidly on c essation of treatment.
prolonged treatment at toxic levels result in dehydration, kidney
damage, weight low and thyroid disturbances.
medical cond aggravated by exposure: no applicable data was found.
First aid: eyes: immediately flush with water for 15 minutes, lifiing
upper and lower lids occasionally. Immediately see a physician.
skin: immediately flush with plenty of water. If irritation
persists seek med ical attention. Inhalation: remove to fresh air.
support respiration if necessary. If breathing discomfort occurs
and persists, see a physician. Ingestion: drink two glasses of
water. Do not induce vo miting! Do not give anything by mouth to an
unconscious person. See a physician immediately.
Hcc: b1
melt/freeze pt: =470.C, 878.F
decomp temp: =924.C, 1695.2f
spec gravity: 1.5
evaporation rate & reference: n/a (butyl acetate=1)
solubility in water: 10% @25c
appearance and odor: white crystals - odorless
Stability indicator/materials to avoid: yes
strong acids, aluminum, zinc
stability condition to avoid: reacts with acids.
hazardous decomposition products: none.
Waste disposal methods: dispose of waste according to federal epa, state
and local regulations.
Ingred name: lithium hydroxide
cas: 1310-65-2
rtecs #: oj6307070
= wt: 99.
other rec limits: none recommended
Ld50 lc50 mixture: unclassified welding fumes=5mg/m3 pel
routes of entry: inhalation: yes skin: yes ingestion: no
reports of carcinogenicity: ntp: yes iarc: yes osha: no
health hazards acute and chronic: bronchial irritation, baritosis,
respiratory tract irritation, metal fume fever, gastrointestinal
upset, pus formation in the conjuctiva, cornea or sclera;
neurological problems; abnormal kidney funct ion; lung fibrosis and
chronic bronchitis.
explanation of carcinogenicity: nickel & crystalline silica have been
identified by iarc and/or ntp as potential cancer causing agents.
effects of overexposure: eye irritation, redness, pain & conjunctivitis;
nausea, vomiting & weakness; excessive salivation, colic, violent
diarrhea, convulsive tremors; intestinal blockage; chills, fever &
sweating; apathy, d rowsiness, spastic gait & paralysis; loss of
consciousness & death.
medical cond aggravated by exposure: pre-existing chronic skin, eye or
respiratory disorders may be aggravated if individuals are
repeatedly overexposed to fumes and dust.
First aid: inhalation: remove from exposure. If severe respiratory
irritation persists, see doctor. Victim may exhibit " metal fume
fever". Eye: flush particles from eye with clean water for 15
minutes. If irrit ation persists see doctor. Skin: was with soap
and water. If rash develops, see doctor. Ingestion: if symptoms of
ingestion arise, see medical help.
Hcc: n1
melt/freeze pt: m.P/f.P text: >1832f
spec gravity: 4-6
appearance and odor: welding electrode is metallic silver colored wire
with a flux coating/flux core
Stability indicator/materials to avoid: yes
hazardous decomposition products: welding and cutting operation may
include oxides of the metals, chromates, fluorides, carbon
monoxide, ozone, toxic gas.
Waste disposal methods: if disposal is necessary, dispose in accordance
with federal, state & local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: barium carbonate
cas: 513-77-9
rtecs #: cq8600000
fraction by wt: 1-5%
other rec limits: none specified
ingred name: calcium carbonate (marble) (limestone)
cas: 1317-65-3
rtecs #: ev9580000
fraction by wt: 1-5%
other rec limits: none specified
osha pel: 15 mg/m3 tdust
acgih tlv: 10 mg/m3 tdust; 9192
ingred name: calcium fluoride
cas: 7789-75-5
rtecs #: ew1760000
fraction by wt: 1-5%
other rec limits: none specified
ingred name: copper (sara iii)
cas: 7440-50-8
rtecs #: gl5325000
fraction by wt: 15-40%
other rec limits: none specified
osha pel: 0.1mg/m3 fume/1 dust
acgih tlv: 0.2mg/m3 fume; 9192
epa rpt qty: 5000 lbs
dot rpt qty: 5000 lbs
ingred name: manganese (sara iii)
cas: 7439-96-5
rtecs #: oo9275000
fraction by wt: 1-5%
other rec limits: none specified
osha pel: (c) 5 mg/m3 dust
acgih tlv: 5 mg/m3 dust 9293
ingred name: sodium fluoaluminate
cas: 15096-52-3
rtecs #: wa9625000
fraction by wt: 5-10%
other rec limits: none specified
osha pel: 2.5 mg/m3
ingred name: sodium silicate
cas: 1344-09-8
fraction by wt: 1-5%
other rec limits: none specified
ingred name: nickel (sara iii)
cas: 7440-02-0
rtecs #: qr5950000
fraction by wt: 40-70%
other rec limits: none specified
osha pel: 1 mg/m3
acgih tlv: 1 mg/m3; 9192
ingred name: silica, crystalline - fused
cas: 60676-86-0
rtecs #: vv7328000
fraction by wt: 1-5%
other rec limits: none specified
osha pel: see table z3
acgih tlv: 0.1 mg/m3 rdust;9293
ingred name: titanium, metal
cas: 7440-32-6
rtecs #: xr1700000
fraction by wt: 1-5%
other rec limits: none specified
ingred name: titanium dioxide
cas: 13463-67-7
rtecs #: xr2275000
fraction by wt: 1-5%
other rec limits: none specified
osha pel: 15 mg/m3 tdust
acgih tlv: 10 mg/m3 tdust; 9293
Ld50 lc50 mixture: oral ld50 (rat) is 225 mg/kg
routes of entry: inhalation: yes skin: no ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: acute: inhalation- irritation of
respiratory tract, burns to mucous membranes, central nervous
system deression. Eyes- irritation, burns. Skin- irritation, burns.
ingestion- central nervous system dep ression, burns to mouth and
esophagus. Chronic: kidney damage, bone marrow damage (aplastic
anemia).
explanation of carcinogenicity: none
effects of overexposure: inhalation: dizziness, headache, coughing,
wheezing, chest pain. Eyes: redness, tearing, burns. Skin: redness,
rash, burns. Ingestion: nausea, vomiting, dizziness, stomach pain.
medical cond aggravated by exposure: preexisting respiratory diseases,
skin disorders, eye conditions.
First aid: inhalation: remove to fresh air. Resuscitate if needed. Skin:
flush with water; remove contaminated clothing. Wash with soap and
water. See doctor. Eyes: flush with water for 15 minutes. See
doctor. I ngestion: do not induce vomiting! Give 1-2 glasses of
water to conscious person. Get immediate medical attention.
Hcc: b3
melt/freeze pt: m.P/f.P text: 880f,471c
spec gravity: 2.54
ph: >11
solubility in water: appreciable
appearance and odor: white powder with suffocating odor
corrosion rate: .23(al)
Stability indicator/materials to avoid: yes
strong mineral acids, metals, combustibles, and water.
stability condition to avoid: contact with incompatibles, extreme
tempreatures and moisture.
hazardous decomposition products: oxides of lithium
Waste disposal methods: dispose of in accordance with local, state and
federal regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: lithium hydroxide solution
cas: 1310-65-2
rtecs #: oj6307070
fraction by wt: 100%
other rec limits: none specified
Ld50 lc50 mixture: none specified by manufacturer.
routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: material is extremely destructive to
tissue of the mucous membranes and upper respiratory tract, eyes
and skin. Inhalation may be fatal as a result of spasm,
inflammation and edema of the larynx and b ronchi, chemical
pneumonitis and pulmonary edema. Large doses of lithium have caused
kidney damage.
explanation of carcinogenicity: this product is not listed by iarc, ntp
or osha as a carcinogen, mutagen, teratogen or neurotoxin.
effects of overexposure: tissue damage, spasm, inflammation and edema of
the larynx and bronchi, chemical pneumonitis, pulmonary edema,
burning sensation, coughing, wheezing, laryngitis, shortness of
breath, headache, nausea and vomiting, kidney damage.
medical cond aggravated by exposure: none specified by manufacturer.
First aid: in case of contact, immediately flush eyes or skin with
copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. Assure adequate flushing of the
eyes by seperat ing the eyelids with fingers. If inhaled, remove to
fresh air. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen. Call a physician.
Hcc: b1
boiling pt: b.P. Text: not given
melt/freeze pt: m.P/f.P text: not given
vapor pres: not given
vapor density: not given
spec gravity: 1.510
ph: > 7
evaporation rate & reference: not given
solubility in water: soluble
appearance and odor: white crystals
Stability indicator/materials to avoid: yes
strong oxidizing agents, strong acids
stability condition to avoid: extreme temperatures, moisture
hazardous decomposition products: nature of decomposition products not
known.
Waste disposal methods: prevent waste from contaminating surrounding
environment. Discard any product, residue, disposal container or
liner in accordance with all federal, state and local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: lithium hydroxide monohydrate
cas: 1310-66-3
rtecs #: oj6307080
fraction by wt: 99.9% +
other rec limits: none recommended
Routes of entry: inhalation: yes skin: yes ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: lithium hydroxide reacts corrosively
w/body moisture causing a burning sensation. If such symptoms
occur, flush area w/lg amts of water. Follow w/neutralizing
solution & see your supervision about the need for further medical
attn.
explanation of carcinogenicity: per msds: lithium hydroxide not listed as
carcinogen or potential carcinogen by ntp/osha/iarc.
effects of overexposure: reacts corrosively w/body moisture causing a
burning sensatin.
medical cond aggravated by exposure: none specified by manufacturer.
First aid: speed in removing matl is critical to avoid severe caustic
burns. Skin: flush w/lg amts of water,if possible,under deluge type
shower.Remove contamin cloth immed.Seek immed med attn. Eyes: flush
w/potab le water for 15mins w/burned eye nearestfloor so chem is
not washed into other eye.Seek immed med attn. Ingest: drink lg
quant for water to dilute matl.Do not induce vomit.Seek immed med
attn.
Hcc: b1
melt/freeze pt: =450.C, 842.F
vapor pres: 0 @20c
solubility in water: soluble.
appearance and odor: white crystals, odorless.
Reacts violently w/acid.
stability condition to avoid: when exposed to air, lithium hydroxide
picks up co2, and cakes over.
hazardous decomposition products: none specified by manufacturer.
Waste disposal methods: neutralize w/dilute acetic acid. Follow state
and local regulations. Emergency response contact for incident
during transp: 800-424-9300(chemtrec).
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: lithium hydroxide
cas: 1310-65-2
rtecs #: oj6307070
fraction by wt: 99%
other rec limits: none recommended
Ld50 lc50 mixture: oral ld50(rat):
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: effects of single overesposure: this
material is corrosive to skin, eyes (may cause blindness), nose,
throat, and respiratory tract. Effects of overexposure: the use of
this product in industrial and commerical applications presents no
significant toxicity hazard. The symptoms described in
signs/symptoms of overexposure are based on therapeutic
applications of lithium carbonate where relatively la rge doses are
taken by medically supervised patients.
explanation of carcinogenicity: this product is not indicated to be
carginogenic.
effects of overexposure: lithium carbonate is used therapeutically at
500 to 2000 mg/day oral doses for specific mental disorders.
therapeutic effects occur at blood levels of 2.8 to 8.3 mg lithium
per liter. Minimal signs of toxicity may also occur at these
therapeutic levels and involve primary gastrointestinal upset.
increased dosages can produce tremors, doowsiness and unsteady
gait. Signs of toxicity resolve rapidly on cessation of treatment.
prolonged treatment at toxic levels result in dehydration, kidney
damage, weight loss and thyroid disturbances.
medical cond aggravated by exposure: no applicable data was found
First aid: eye: immediately flush with wate for 15 minutes, lifting
upper and lower lids occasionally. Immediately see a physician.
skin: immediately flush with plenty of water. If irritation
persists seek medic al attention. Inhalation: remove to fresh air.
support respiration if necessary. If breathing discomfort occurs
and persists, see a physician. Ingestion: drink two glasses of
water. Do not induce vomi ting. Do not give anything by mouth to an
unconscious person. See a physician immediately.
Hcc: b1
melt/freeze pt: =243.3c, 470.F
decomp temp: decomp text: none provided by mfr
spec gravity: 1.5 g/cc
ph: none provided
viscosity: none provided by mfr
solubility in water: 10 wt% by wt @ 77 f (25c)
appearance and odor: white crystals, odorless
percent volatiles by volume: none provide
corrosion rate: none provided by mfr
Stability indicator/materials to avoid: yes
strong acids, aluminum, zinc
stability condition to avoid: none
hazardous decomposition products: none
conditions to avoid polymerization: will not occur. Reacts with acids
Waste disposal methods: dispose of waste according to federal epa, state
and local regulations
Ingred name: lithium hydroxide
cas: 1310-65-2
rtecs #: oj6307070
= wt: 99.
other rec limits: 2 mg/m3